In the last of her five-part series, contributor Lori Weiman takes a deep dive into FDA guidelines and explains how pharmaceutical advertisers and their partners can avoid costly violations.
Please visit Marketing Land for the full article.
source https://jessicaevieblog.wordpress.com/2016/09/02/how-to-manage-ad-partners-in-regulated-industries-pharma-part-5-of-5/
No comments:
Post a Comment